Mednet Logo
HomeEndocrinology
Endocrinology

Endocrinology

Physician discussions on diabetes management, thyroid disorders, hormonal imbalances, and metabolic conditions.

Recent Discussions

Can fatty liver disease present with elevations in alkaline phosphatase without other liver enzyme elevations (AST and ALT)?

2
1 Answers

Mednet Member
Mednet Member
Hepatology · Mount Sinai Hospital

It is very atypical but can occur. Patients usually have elevations in aminotransferases (usually ALT higher than AST) and there can be very mild concurrent elevations in alkaline phosphatase. An isolated alkaline phosphatase elevation should however prompt a more extensive serological work up as we...

How do you approach individualizing A1c goals in patients with dementia?

2 Answers

Mednet Member
Mednet Member
Geriatric Medicine · Hackensack Meridian School of Medicine

This is an important question for shared decision-making. And it definitely is impacted by the severity/FAST staging of the dementia, as well as the class of medication use. As we are all aware, we do not want to use the Sulfonylurea class in older adults, especially in patients with a dementia diag...

Is there a role for cinacalcet in the management of PTHrP-mediated hypercalcemia?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Boston University School of Medicine

Cinacalcet is a calcimimetic, meaning that it mimics calcium and interacts with the calcium sensor in the parathyroid glands, which is a signal to decrease the production of PTH. Cinacalcet will not decrease the production of PTHRP in cancer cells. However, cinacalcet will decrease the production of...

How do you approach osteoporosis screening in men?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · University of California, Irvine

While osteoporosis is more prevalent in postmenopausal women, it is often under-recognized in men. The risk of mortality after hip fracture is higher in men, and that risk may extend over 10 years after injury. Men who sustain a wrist fracture are more likely to have severe osteoporosis and a higher...

Is there an evidence-based consensus on CT-derived Hounsfield unit thresholds for opportunistic assessment of osteoporosis, and how should such measurements be applied when DXA results are inconclusive or do not meet diagnostic criteria?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Milwaukee Va Medical Center

Per the International Society for Clinical Densitometry's official positions: "Opportunistic CT-based attenuation using Hounsfield Units (HU) can be used to estimate the likelihood of osteoporosis (L1 HU < 100) and normal (L1 HU > 150) bone density to support decisions regarding bone health assessm...

How do you decide when to treat hypocalcemia in hospitalized patients?

1 Answers

Mednet Member
Mednet Member
Hospital Medicine · UT Health San Antonio

When I think about when to treat hypocalcemia in hospitalized patients, I anchor the decision on three things: symptoms, the absolute calcium level, and the trajectory. First, it’s important to confirm true hypocalcemia: either a serum calcium <8 mg/dL or an ionized calcium <1.1 mmol/L, and to consi...

What is your approach to diagnosing insulin allergy in patients with diabetes?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Michigan State University College of Human Medicine

Insulin allergy, though uncommon since the advent of recombinant human insulin (estimated prevalence ~2%), remains a serious clinical concern. It can manifest as type I (IgE-mediated), type III (immune complex-mediated), or type IV (T-cell-mediated) hypersensitivity, ranging from local cutaneous rea...

When starting GLP-1 R agonist therapy for weight loss purposes, how do you counsel patients on duration of treatment therapy?

1
1 Answers

Mednet Member
Mednet Member
Endocrinology · Emory University School of Medicine

I counsel people that I expect this to be lifelong therapy (similar to how we don't stop blood pressure medications when blood pressure comes down to normal on them because it will go back up, we don't stop GLP1RA when we get to our weight goals, as our weight will go back up when they are stopped)....

Can autoimmune thyroiditis present with recurrent angioedema and bronchospasm?

1 Answers

Mednet Member
Mednet Member
Endocrinology · Oregon Health Sciences University Portland State University School Of Public Hea

There is an association between angioedema and autoimmune thyroid disease, although the incidence is not known. Activated CD4+ T lymphocytes, monocytes, and eosinophils. The incidence of thyroid autoimmunity in chronic urticaria is similar to the background population, but there is a cluster of angi...

Should GLP-1 agonists be held during chemotherapy?

5
3 Answers

Mednet Member
Mednet Member
Endocrinology · Brigham And Womens Hospital Endocrinology

I think there are several aspects to this question. First, is there evidence that as a class GLP-1 RAs increase the risk of cancer or worsen prognosis during cancer? I could find nothing to raise concerns about outcomes. One recent report even showed a decreased risk of some cancers with GLP-1 RA co...